Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy

Patients receiving anti–tumor necrosis factor-α (anti–TNF-α) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch databa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Winthrop, Kevin L., Chang, Eric, Yamashita, Shellie, Iademarco, Michael F., LoBue, Philip A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Centers for Disease Control and Prevention 2009
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2866401/
https://ncbi.nlm.nih.gov/pubmed/19861045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1510.090310
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak